chatfield pharmaceuticals limited

0.5

chatfield pharmaceuticals limited Company Information

Share CHATFIELD PHARMACEUTICALS LIMITED
Live 
MatureMicroLow

Company Number

01003809

Registered Address

2 leman street, london, E1W 9US

Industry

Manufacture of basic pharmaceutical products

 

Telephone

02073704664

Next Accounts Due

43 days late

Group Structure

View All

Directors

David Solomon24 Years

Charmian Solomon24 Years

Shareholders

david louis charles solomon 63%

jane celia frances soloman 37%

chatfield pharmaceuticals limited Estimated Valuation

£480.1k

Pomanda estimates the enterprise value of CHATFIELD PHARMACEUTICALS LIMITED at £480.1k based on a Turnover of £401.6k and 1.2x industry multiple (adjusted for size and gross margin).

chatfield pharmaceuticals limited Estimated Valuation

£0

Pomanda estimates the enterprise value of CHATFIELD PHARMACEUTICALS LIMITED at £0 based on an EBITDA of £-57.8k and a 5.52x industry multiple (adjusted for size and gross margin).

chatfield pharmaceuticals limited Estimated Valuation

£364.5k

Pomanda estimates the enterprise value of CHATFIELD PHARMACEUTICALS LIMITED at £364.5k based on Net Assets of £143.1k and 2.55x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Chatfield Pharmaceuticals Limited Overview

Chatfield Pharmaceuticals Limited is a live company located in london, E1W 9US with a Companies House number of 01003809. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in March 1971, it's largest shareholder is david louis charles solomon with a 63% stake. Chatfield Pharmaceuticals Limited is a mature, micro sized company, Pomanda has estimated its turnover at £401.6k with low growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Chatfield Pharmaceuticals Limited Health Check

Pomanda's financial health check has awarded Chatfield Pharmaceuticals Limited a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 9 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating0.5out of 5
positive_score

0 Strong

positive_score

2 Regular

positive_score

9 Weak

size

Size

annual sales of £401.6k, make it smaller than the average company (£30.7m)

£401.6k - Chatfield Pharmaceuticals Limited

£30.7m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 1%, show it is growing at a slower rate (3.6%)

1% - Chatfield Pharmaceuticals Limited

3.6% - Industry AVG

production

Production

with a gross margin of 38.4%, this company has a comparable cost of product (38.4%)

38.4% - Chatfield Pharmaceuticals Limited

38.4% - Industry AVG

profitability

Profitability

an operating margin of -14.7% make it less profitable than the average company (6.5%)

-14.7% - Chatfield Pharmaceuticals Limited

6.5% - Industry AVG

employees

Employees

with 2 employees, this is below the industry average (135)

2 - Chatfield Pharmaceuticals Limited

135 - Industry AVG

paystructure

Pay Structure

on an average salary of £58.3k, the company has an equivalent pay structure (£58.3k)

£58.3k - Chatfield Pharmaceuticals Limited

£58.3k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £200.8k, this is less efficient (£277.9k)

£200.8k - Chatfield Pharmaceuticals Limited

£277.9k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 80 days, this is later than average (56 days)

80 days - Chatfield Pharmaceuticals Limited

56 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 3 days, this is quicker than average (40 days)

3 days - Chatfield Pharmaceuticals Limited

40 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Chatfield Pharmaceuticals Limited

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 2 weeks, this is less cash available to meet short term requirements (12 weeks)

2 weeks - Chatfield Pharmaceuticals Limited

12 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 82.4%, this is a higher level of debt than the average (46.2%)

82.4% - Chatfield Pharmaceuticals Limited

46.2% - Industry AVG

CHATFIELD PHARMACEUTICALS LIMITED financials

EXPORTms excel logo

Chatfield Pharmaceuticals Limited's latest turnover from December 2022 is estimated at £401.6 thousand and the company has net assets of £143.1 thousand. According to their latest financial statements, we estimate that Chatfield Pharmaceuticals Limited has 2 employees and maintains cash reserves of £27.7 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Sep 2009
Turnover401,587366,204355,490391,722376,387355,460750,19923,22621,903,79513,777,9273,165,84111,679,4798,001,8430
Other Income Or Grants00000000000000
Cost Of Sales247,345218,721215,713236,870222,784218,041460,17614,15613,637,0498,685,0122,009,5427,407,3935,074,6580
Gross Profit154,242147,483139,776154,852153,603137,419290,0239,0708,266,7465,092,9151,156,2994,272,0862,927,1850
Admin Expenses213,205221,284102,884-159,827148,500155,559982,0261,067,3307,968,2014,904,5691,138,1644,704,4933,013,847-2,596,192
Operating Profit-58,963-73,80136,892314,6795,103-18,140-692,003-1,058,260298,545188,34618,135-432,407-86,6622,596,192
Interest Payable00000000000000
Interest Receivable1,086801531,2669409654521,6911,5853782318671,190484
Pre-Tax Profit-57,877-73,72137,046315,9446,043-17,175-691,551-1,056,569300,130188,72518,366-431,540-85,4722,596,676
Tax00-7,039-60,029-1,148000-63,027-43,407-4,40800-727,069
Profit After Tax-57,877-73,72130,007255,9154,895-17,175-691,551-1,056,569237,103145,31813,958-431,540-85,4721,869,607
Dividends Paid00000000000000
Retained Profit-57,877-73,72130,007255,9154,895-17,175-691,551-1,056,569237,103145,31813,958-431,540-85,4721,869,607
Employee Costs116,681111,65655,637115,845104,525103,222241,51448,8244,596,5842,943,238627,5332,103,5071,460,6510
Number Of Employees2212225198671552360
EBITDA*-57,843-72,96538,000315,1115,724-15,892-687,057-1,053,302303,232192,34221,355-424,856-67,3722,615,115

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Sep 2009
Tangible Assets1,7261,5142,3503,4585461,1673,4157,27410,8349,0154,0397,25914,45123,247
Intangible Assets00000000000000
Investments & Other0000000000897,665897,665897,665897,665
Debtors (Due After 1 year)00000000000000
Total Fixed Assets1,7261,5142,3503,4585461,1673,4157,27410,8349,015901,704904,924912,116920,912
Stock & work in progress000000000000739,4961,599,150
Trade Debtors88,76474,73382,69300004,6913,704,3982,568,233601,3781,892,5081,327,9331,393,005
Group Debtors00000000000000
Misc Debtors694,983757,920710,133435,371405,545372,676382,7673,771,105000000
Cash27,73134,33929,920276,98660,522190,071195,815165,526510,881123,31228,02664,216282,399193,653
misc current assets00000000000000
total current assets811,478866,992822,746712,357466,067562,747578,5823,941,3224,215,2792,691,545629,4041,956,7242,349,8283,185,808
total assets813,204868,506825,096715,815466,613563,914581,9973,948,5964,226,1132,700,5601,531,1082,861,6483,261,9444,106,720
Bank overdraft00000000000000
Bank loan00000000000000
Trade Creditors 2,4843,1204,9184,2384,3883,7133,0241,6342,477,0391,188,589164,4551,508,9531,477,7092,237,013
Group/Directors Accounts00000000000000
other short term finances00000000000000
hp & lease commitments00000000000000
other current liabilities667,294664,032545,482466,888473,451576,322577,9193,254,357000000
total current liabilities669,778667,152550,400471,126477,839580,035580,9433,255,9912,477,0391,188,589164,4551,508,9531,477,7092,237,013
loans00000000000000
hp & lease commitments00000000000000
Accruals and Deferred Income00000000000000
other liabilities00000000000000
provisions328379000000000000
total long term liabilities328379000000000000
total liabilities670,106667,531550,400471,126477,839580,035580,9433,255,9912,477,0391,188,589164,4551,508,9531,477,7092,237,013
net assets143,098200,975274,696244,689-11,226-16,1211,054692,6051,749,0741,511,9711,366,6531,352,6951,784,2351,869,707
total shareholders funds143,098200,975274,696244,689-11,226-16,1211,054692,6051,749,0741,511,9711,366,6531,352,6951,784,2351,869,707
Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Sep 2009
Operating Activities
Operating Profit-58,963-73,80136,892314,6795,103-18,140-692,003-1,058,260298,545188,34618,135-432,407-86,6622,596,192
Depreciation1,1208361,1084326212,2484,9464,9584,6873,9963,2207,55119,29018,923
Amortisation00000000000000
Tax00-7,039-60,029-1,148000-63,027-43,407-4,40800-727,069
Stock00000000000-739,496-859,6541,599,150
Debtors-48,90639,827357,45529,82632,869-10,091-3,393,02971,3981,136,1651,966,855-1,291,130564,575-65,0721,393,005
Creditors-636-1,798680-1506756891,390-2,475,4051,288,4501,024,134-1,344,49831,244-759,3042,237,013
Accruals and Deferred Income3,262118,55078,594-6,563-102,871-1,597-2,676,4383,254,357000000
Deferred Taxes & Provisions-51379000000000000
Cash flow from operations-6,3624,339-247,220218,543-130,489-6,70930,924-345,748392,490-793,786-36,421-218,69198,0501,132,904
Investing Activities
capital expenditure-1,33200-3,34400-1,087-1,398-6,506-8,9720-359-10,494-42,170
Change in Investments000000000-897,665000897,665
cash flow from investments-1,33200-3,34400-1,087-1,398-6,506888,6930-359-10,494-939,835
Financing Activities
Bank loans00000000000000
Group/Directors Accounts00000000000000
Other Short Term Loans 00000000000000
Long term loans00000000000000
Hire Purchase and Lease Commitments00000000000000
other long term liabilities00000000000000
share issue000000010000000100
interest1,086801531,2669409654521,6911,5853782318671,190484
cash flow from financing1,086801531,2669409654521,7911,5853782318671,190584
cash and cash equivalents
cash-6,6084,419-247,066216,464-129,549-5,74430,289-345,355387,56995,286-36,190-218,18388,746193,653
overdraft00000000000000
change in cash-6,6084,419-247,066216,464-129,549-5,74430,289-345,355387,56995,286-36,190-218,18388,746193,653

chatfield pharmaceuticals limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for chatfield pharmaceuticals limited. Get real-time insights into chatfield pharmaceuticals limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Chatfield Pharmaceuticals Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for chatfield pharmaceuticals limited by selecting its closest rivals, whether from the MANUFACTURING sector, other micro companies, companies in E1W area or any other competitors across 12 key performance metrics.

chatfield pharmaceuticals limited Ownership

CHATFIELD PHARMACEUTICALS LIMITED group structure

Chatfield Pharmaceuticals Limited has no subsidiary companies.

Ultimate parent company

CHATFIELD PHARMACEUTICALS LIMITED

01003809

CHATFIELD PHARMACEUTICALS LIMITED Shareholders

david louis charles solomon 63%
jane celia frances soloman 37%

chatfield pharmaceuticals limited directors

Chatfield Pharmaceuticals Limited currently has 2 directors. The longest serving directors include Mr David Solomon (Jul 2000) and Mrs. Charmian Solomon (Jul 2000).

officercountryagestartendrole
Mr David SolomonUnited Kingdom54 years Jul 2000- Director
Mrs. Charmian Solomon88 years Jul 2000- Director

P&L

December 2022

turnover

401.6k

+10%

operating profit

-59k

0%

gross margin

38.5%

-4.63%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2022

net assets

143.1k

-0.29%

total assets

813.2k

-0.06%

cash

27.7k

-0.19%

net assets

Total assets minus all liabilities

chatfield pharmaceuticals limited company details

company number

01003809

Type

Private limited with Share Capital

industry

21100 - Manufacture of basic pharmaceutical products

incorporation date

March 1971

age

53

incorporated

UK

ultimate parent company

None

accounts

Total Exemption Full

last accounts submitted

December 2022

previous names

N/A

accountant

GRAVITA 111 LLP

auditor

-

address

2 leman street, london, E1W 9US

Bank

-

Legal Advisor

-

chatfield pharmaceuticals limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to chatfield pharmaceuticals limited.

charges

chatfield pharmaceuticals limited Companies House Filings - See Documents

datedescriptionview/download